Specifications
Immunogen
Synthetic peptide, corresponding to a region within C terminal amino acids 261-323 of Human AKR1C3.
Applications
Application Notes
WB: 1/500 - 1/3000; IHC-P: 1/100 - 1/1000; ICC/IF: 1/100 - 1/1000.
Target
Alternative Names
AKR1C3; aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II); HSD17B5, hydroxysteroid (17 beta) dehydrogenase 5; aldo-keto reductase family 1 member C3; DDX; dihydrodiol dehydrogenase X; HAKRB; KIAA0119; PGFS; prostaglan
Product Background
Antigen Description
Catalyzes the conversion of aldehydes and ketones to alcohols. Catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ) and the oxidation of 9-alpha,11-beta-PGF2 to PGD2. Functions as a bi-directional 3-alpha-, 17-beta- and 20-alpha HSD. Can interconvert active androgens, estrogens and progestins with their cognate inactive metabolites. Preferentially transforms androstenedione (4-dione) to testosterone.
Pathway
Arachidonic acid metabolism; Metabolism of xenobiotics by cytochrome P450; Steroid hormone biosynthesis; androgen biosynthesis;
Citations
Publication ()
Have you cited DPABH-00576 in a publication?
Let us know and earn a reward for your research.